Products

What will AGI do for Azaperone?

This classification denotes an antipsychotic agent with the molecular formula C19H22FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19BV78AK7W, chemically known as 1-butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)- but generally known as azaperone, which bears US NIH Compound Identifier 15443. Azaperone most often comes in base and dimaleate forms. European Medicines Agency schedules Azaperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05636MIG. The term AZAPERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). AZAPERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azaperone under HS 29335995 and SITC 51576. As of Q4 2014, AZAPERONE remains the US FDA Preferred Term for this commodity. Azaperone bears US NLM identifiers UMLS ID C0004477 and NCI Concept Code C74187. SMILES: FC1CCC(C(=O)CCCN2CCN(CC2)C2NCCCC2)CC1.

How AGI delivers it

Four ways AGI delivers for Azaperone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Azaperone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Azaperone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Azaperone connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Compound Puritymodel
  • Impurity Contentmodel
  • Melting Pointmodel
  • Residual Solventmodel